USPTO serial 79431008
IODAX
Reviewed by CopyMark Law Group
Status 802
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IODAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations; radioactive pharmaceutical preparations for in vivo diagnostics; radioactive pharmaceutical preparations for therapeutic use; radioactive substances for medical purposes; radioactive elements being substances for medical use; sealed radioactive substances for medical use; radio-isotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for veterinary diagnosis being diagnostic use; radiological contrast substances for medical purposes; contrasting agents for diagnostic ultrasound imaging; diagnostic reagents and contrast media for medical use; diagnostic agents for pharmaceutical use; none of the aforesaid being in relation to medicines containing iron, oral iron compositions for the treatment of iron deficiency and/or anaemia | ACTIVE | — |
| 010 | Radioisotope therapy apparatus and instruments; radiation oncology apparatus for medical use; radio cardiographic apparatus for medical purposes; apparatus for radionuclide imaging for medical use | ACTIVE | — |
| 042 | Research in the field of interventional radiology; research relating to radiopharmaceuticals, radiotherapeutics and radiodiagnostics; development of radiopharmaceutical preparations and medications and radiodiagnostics and radiotherapeutics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Theranostik Pharma GmbH
- Other trademarks owned by IODAX Pharma AG
- Other trademarks owned by IODAX Pharma AG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named IODAX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 23, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 23, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 17, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 29, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 18, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 28, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 28, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 15, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 9, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 29, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |